azithromycin
A macrolide antibiotic useful for the treatment of bacterial infections.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
macrolide antibioticARO:0000000
- macrolide antibiotic
CHEBI:25105 - macrolide antibiotic
ARO:0000000
Chemical structure
| Molecular formula | C38H72N2O12 |
|---|---|
| Charge | 0 |
| Average mass | 748.996 Da |
| Monoisotopic mass | 748.50853 Da |
| Source | ChEBI |
| InChIKey | MQTOSJVFKKJCRP-BICOPXKESA-N |
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
Also called
- Azenil
- Azifast
- Azigram
- Azimakrol
- Azitromin
- Hemomycin
- Zithromax
- Zmax
- azithromycine
- azithromycinum
- azitromicina
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranoside
- (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
- AZM
Cross-references
- azithromycin
ARO:3000158 - cas:83905-01-5
- hmdb:HMDB0014352
- kegg.compound:C06838
- lincs.smallmolecule:LSM-5821
- pdb-ccd:ZIT
- reaxys:5387583
- reaxys:8820027
- chembl:CHEMBL529
- pubchem.compound:447043
Drug registries
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281 - antibacterial drug
CHEBI:36047
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3000158 |
azithromycin | antibioticmech:aro-904736d7d5 |
2026-08-30 |
| CHEBI | CHEBI:2955 |
azithromycin | antibioticmech:chebi-8c555420d7 |
2026-08-30 |
Molecular targets
50S ribosomal subunit P-site RIBOSOMAL_SUBUNIT DIRECT_BINDING_TARGET
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Mycobacterium tuberculosis complex | RESISTANT | — | — | CRyPTIC DST; SEQTREAT2020; solid media; middlebrook; 7H10; critical concentration 3.0 mg/L | — |
6 source isolates 6 measurements |
EvidencePage data (JSON.gz) |
| Neisseria gonorrhoeae NCBITaxon:485 | — | 2.0 mg/L | — | Azithromycin MIC; interpreted using CLSI 2026 M100 Ed36. | 1281 |
BioSample SAMN35332251 |
EvidencePage data (JSON.gz) |
Resistance mechanisms
ANTIBIOTIC_TARGET_ALTERATION 32
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Chlamydia trachomatis 23S rRNA with mutation conferring resistance to macrolide antibiotics | ARO:3004174 | — | ||
| Erm(33) | ARO:3000599 | — | ||
| Erm(34) | ARO:3000600 | — | ||
| Erm(35) | ARO:3000604 | — | ||
| Erm(36) | ARO:3000605 | — | ||
| Erm(37) | ARO:3000392 | — | ||
| Erm(38) | ARO:3000601 | — | ||
| Erm(39) | ARO:3000602 | — | ||
| Erm(41) | ARO:3000603 | — | ||
| Erm(47) | ARO:3003908 | — | ||
| Erm(51) | ARO:3007033 | — | ||
| ErmA | ARO:3000347 | — | ||
| ErmB | ARO:3000375 | — | ||
| ErmC | ARO:3000250 | — | ||
| ErmD | ARO:3000495 | — | ||
| ErmE | ARO:3000326 | — | ||
| ErmF | ARO:3000498 | — | ||
| ErmG | ARO:3000522 | — | ||
| ErmN | ARO:3000592 | — | ||
| ErmQ | ARO:3000593 | — | ||
| ErmR | ARO:3000594 | — | ||
| ErmT | ARO:3000595 | — | ||
| ErmX | ARO:3000596 | — | ||
| ErmY | ARO:3002825 | — | ||
| Moraxella catarrhalis 23S rRNA with mutation conferring resistance to macrolide antibiotics | ARO:3004138 | — | ||
| Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin | ARO:3004167 | — | ||
| Mycoplasma genitalium 23S rRNA mutations confers resistance to fluoroquinolone and macrolide antibiotics | ARO:3004616 | — | ||
| Mycoplasma hominis 23S rRNA with mutation conferring resistance to macrolide antibiotics | ARO:3004176 | — | ||
| Neisseria gonorrhoeae 23S rRNA with mutation conferring resistance to azithromycin | ARO:3004836 | — | ||
| Neisseria gonorrhoeae rpld | ARO:3004956 | — | ||
| erm(46) | ARO:3004596 | — | ||
| erm(55) | ARO:3009647 | — |
ANTIBIOTIC_INACTIVATION 11
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| EreB | ARO:3000363 | — | ||
| Mrx | ARO:3003839 | — | ||
| mgtA | ARO:3000462 | — | ||
| mphA | ARO:3000316 | — | ||
| mphB | ARO:3000318 | — | ||
| mphC | ARO:3000319 | — | ||
| mphF | ARO:3003071 | — | ||
| mphG | ARO:3003742 | — | ||
| mphH | ARO:3004539 | — | ||
| mphK | ARO:3004541 | — | ||
| mphL | ARO:3003072 | — |
ANTIBIOTIC_EFFLUX 10
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| AmrAB-OprM | ARO:3002981 | — | ||
| Klebsiella pneumoniae KpnGH-TolC | ARO:3004598 | — | ||
| LpeAB | ARO:3004098 | — | ||
| MexAB-OprM | ARO:3000386 | — | ||
| MtrCDE | ARO:3000369 | — | ||
| Neisseria gonorrhoeae mtrR with mutation conferring resistance | ARO:3004851 | — | ||
| lmrP | ARO:3003969 | — | ||
| mef(B) | ARO:3003107 | — | ||
| mef(F) | ARO:3007044 | — | ||
| mreA | ARO:3007050 | — |
ANTIBIOTIC_TARGET_PROTECTION 1
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| msr(G) | ARO:3007042 | — |
UNKNOWN 1
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| mef(F)/msr(G)-associated reduced azithromycin susceptibility in native isolate Epi0082 |
— | Macrococcoides canis NCBITaxon:1855823 |
mef(F), msr(G) |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
CURATED_RESISTANT_TAXA
Added one stable-URL CDC/FDA AR Isolate Bank Panel 10 azithromycin-resistant Neisseria gonorrhoeae activity observation for AR-1281.
-
STRUCTURED_ACTIVITY_BIOSAMPLE_ACCESSIONS
Structured BioSample accessions on 1 activity_spectrum observation(s) where evidence notes already named exactly one accession.
-
RESEEDED_FROM_SOURCES
Re-seeded; changed: activity_spectrum (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.
-
RESEEDED_FROM_SOURCES
Re-seeded; changed: activity_membership_collections (CRYPTIC 3.4.0). Upstream retrieval date 2026-08-30, unchanged.
-
CURATED_RESISTANCE_EVIDENCE
Added one native Epi0082 mef(F)/msr(G) and azithromycin co-occurrence claim with verified species-name and source-reported genome-component context. Kept the different-species UniProt reference and expression-host experiment separate; preserved every source-owned claim and membership. Whole-record review remains open.